Weekly Investment Analysts’ Ratings Updates for Procter & Gamble (PG)

Posted by Stanley Muller on Nov 4th, 2026

Several analysts have recently updated their ratings and price targets for Procter & Gamble (NYSE: PG):

10/27/2026 – Procter & Gamble was downgraded by DZ Bank from “strong-buy” to “hold”.
10/26/2026 – Procter & Gamble had its price target raised by Piper Sandler from $145.00 to $167.00. They now have a “neutral” rating on the stock.
10/26/2026 – Procter & Gamble had its price target raised by Barclays from $152.00 to $165.00. They now have an “equal weight” rating on the stock.
10/23/2026 – Procter & Gamble was given a new $166.00 price target by UBS Group.
10/23/2026 – Procter & Gamble had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft.
10/23/2026 – Procter & Gamble was given a new $169.00 price target by Royal Bank Of Canada.
10/23/2026 – Procter & Gamble had its price target raised by Morgan Stanley from $166.00 to $185.00. They now have an “overweight” rating on the stock.
10/23/2026 – Procter & Gamble had its price target raised by Wells Fargo & Company from $164.00 to $180.00. They now have an “overweight” rating on the stock.
10/23/2026 – Procter & Gamble was upgraded by Freedom Broker from “hold” to “buy”. They now have a $176.00 price target on the stock.
10/23/2026 – Procter & Gamble had its price target raised by UBS Group from $172.00 to $190.00. They now have a “buy” rating on the stock.
10/23/2026 – Procter & Gamble had its price target raised by Citigroup from $180.00 to $187.00. They now have a “buy” rating on the stock.
10/23/2026 – Procter & Gamble had its price target raised by BNP Paribas Exane from $177.00 to $189.00. They now have an “outperform” rating on the stock.
10/23/2026 – Procter & Gamble had its price target raised by JPMorgan Chase & Co. from $162.00 to $180.00. They now have an “overweight” rating on the stock.
10/23/2026 – Procter & Gamble had its price target raised by TD Cowen from $150.00 to $166.00. They now have a “hold” rating on the stock.
10/22/2026 – Procter & Gamble had its “neutral” rating reaffirmed by The Goldman Sachs Group. They now have a $161.00 price target on the stock.
10/20/2026 – Procter & Gamble had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $166.00 price target on the stock.
10/16/2026 – Procter & Gamble had its “buy” rating reaffirmed by UBS Group.
10/9/2026 – Procter & Gamble had its price target raised by Citigroup from $170.00 to $180.00. They now have a “buy” rating on the stock.
10/6/2026 – Procter & Gamble was upgraded by Evercore from “in-line” to “outperform”. They now have a $166.00 price target on the stock.
10/6/2026 – Procter & Gamble had its price target lowered by Royal Bank Of Canada from $167.00 to $166.00. They now have an “outperform” rating on the stock.
9/30/2026 – Procter & Gamble had its “hold” rating reaffirmed by TD Cowen. They now have a $150.00 price target on the stock.
9/21/2026 – Procter & Gamble had its “hold (c)” rating reaffirmed by Weiss Ratings.

Procter & Gamble Trading Up 3.5%

PG stock traded up $5.74 during midday trading on Wednesday, hitting $167.80. The company had a trading volume of 4,570,640 shares, compared to its average volume of 9,710,205. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.86. The stock’s 50 day moving average price is $150.68 and its 200 day moving average price is $149.12. The stock has a market cap of $388.92 billion, a price-to-earnings ratio of 25.27, a PEG ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. During the same quarter in the prior year, the firm posted $1.99 earnings per share. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. As a group, equities research analysts expect that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.6%. Procter & Gamble’s dividend payout ratio is presently 65.51%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Victor Aguilar sold 18,812 shares of the business’s stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $164.43, for a total value of $3,093,257.16. Following the transaction, the insider owned 55,243 shares in the company, valued at approximately $9,083,606.49. The trade was a 25.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Sundar G. Raman sold 38,253 shares of the company’s stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $165.00, for a total transaction of $6,311,745.00. Following the transaction, the chief executive officer directly owned 47,745 shares of the company’s stock, valued at approximately $7,877,925. This trade represents a 44.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 128,085 shares of company stock worth $20,696,098 over the last ninety days. 0.23% of the stock is owned by company insiders.

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.